Perianal and anal canal neoplasms

Principles and Practice of Surgery for the Colon, Rectum, and Anus, Third Edition

Volumn , Issue , 2007, Pages 369-390

  Nivatvongs, Santhat ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952288051     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (166)

1. Fenger C, Frisch M, Marti MC, Parc R. Tumors of the anal canal. Hamilton SR, Aaltonen LA, eds. WHO classification of tumors. Pathology and genetics of tumors of the digestive system. Lyon, France: International Agency for Research on Cancer (IARC), 2002:146-155.
2. Green FL, Page DL, Fleming ID, et al. American Joint Committee on Cancer. 6th ed. New York: Springer-Verlag, 2002:139-144, 231-237.
3. Cummings BJ. [Editorial]. Oncology 1996; 10:1853-1854.
4. Jensen SL, Hagen K, Shokouh-Amiri MH, Nielsen OV. Does an erroneous diagnosis of squamous-cell carcinoma of the anal canal and anal margin at first physician visit influence prognosis?. Dis Colon Rectum 1987; 30:345-351.
5. Williams GR, Talbot IC. Anal carcinoma—a histological review. Histopathology 1994; 25:507-516.
6. Brown DK, Ogelsby AB, Scott DH, Dayton MT. Squamous cell carcinoma of the anus. A twenty-five year retrospective. Am Surg 1988; 54:337-342.
7. Greenall MJ, Quan SHQ, Urmacher C, DeCosse JJ. Treatment of epidermoid carcinoma of the anal canal. Surg Gynecol Obstet 1985; 161:509-517.
8. Pintor MP, Northover JMA, Nicholls RJ. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984. Br J Surg 1989; 76:806-810.
9. Nigro ND. Multidisciplinary management of cancer of the anus. World J Surg 1987; 11:446-451.
10. Bal DG. Cancer statistics 2001: quo vadis or whither goest thou? CA Cancer J Clin 2001; 51:11-14.
11. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics 2005. CA Cancer J Clin 2005; 5:10-30.
12. Deans GT, McAlee JJA, Spence RAJ. Malignant anal tumors. Br J Surg 1994; 81:501-508.
13. Maggard M, Beanes SR, Ko CY. Anal canal cancer: a population-based reappraisal. Dis Colon Rectum 2003; 46:1517-1524.
14. Frisch M. On the etiology of anal squamous carcinoma. Dan Med Bull 2002; 49:194-209.
15. Chang GJ, Sheldon A, Welton ML. Epidemiology and natural history of anal HPV infection and ASIL and cancer in the general population. Semin Colon Rect Surg 2004; 15:210-214.
16. Saclarides TJ, Klem D. Genetic alterations and virology of anal cancer. Semin Colon Rectal Surg 1995; 6:131-134.
17. Palmer JG, Scholefield JH, Coates PJ, et al. Anal cancer and human papillomaviruses. Dis Colon Rectum 1989; 32:1016-1022.
18. Shroyer KR, Kim JG, Manos MM, Greer CE, Pearlman NW, Franklin WA. Papillomavirus found in anorectal squamous carcinoma, not in colon adenocarcinoma. Arch Surg 1992; 127:741-744.
19. Bjorget B, Engeland A, Luostarinen T, et al. Human papilloma virus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 2002; 87:61-64.
20. Fisch M, Glimelius B, Van Den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. NEJM 1997; 337:1350-1358.
21. Welton ML. Etiology of human papilloma virus infections and the development of anal squamous intraepithelial lesions. Semin Colon Rectal Surg 2004; 15:193-195.
22. Mullerat J, Northover J. Human papilloma virus and anal neoplastic lesions in the immunocompromised (Transplant) patient. Semin Colon Rectal Surg 2004; 15:215-217.
23. Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer 1986; 58:611-616.
24. Gervaz P, Hahnloser D, Wolff BG, et al. Molecular biology of squamous cell carcinoma of the anus: a comparison of HIV positive and HIV-negative patients. J Gastrointest Surg 2004; 8:1024-1031.
25. Noffsinger A, Witte D, Fenoglio-Preiser CM. The relationship of human papillomaviruses to anorectal neoplasia. Cancer 1992; 70:1276-1287.
26. Cummings BJ. Anal canal carcinoma. Hermanek P, Gaspodarowicz MK, Henson DE, Hutter RVP, Sobin LH, eds. Prognostic Factors in Cancer. New York: Springer, 1995:80-87.
27. Carter PS. Anal cancer—current perspectives. Dig Dis 1993; 11:239-251.
28. Welton ML, Winkler B, Darragh TM. Anal-rectal cytology and anal cancer screening. Semin Colon Rectal Surg 2004; 15:196-200.
29. Polefsky JM. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol 2000; 27:471-479.
30. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefasky JM. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 2000; 108:634-641.
31. Sholefield JH, Johnson J, Hitchcock A, et al. Guidelines for anal cytology—to make cytological diagnosis and follow up much more reliable. Cytopathology 1998; 9:15-22.
32. Chang GJ, Welton ML. Anal neoplasia. Seminars Colon Rectal Surg 2003; 14:111-118.
33. Goldstone SE, Winkler B, Wifford LJ, Alt E, Polefsky JM. High prevalence of anal squamous intraepithelial lesions and squamous-cell carcinoma in men who have sex with men as seen in a surgical practice. Dis Colon Rectum 2001; 44:690-698.
34. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. NEJM 2002; 347:1645-1651.
35. Stanberry LR. A human papillomavirus type 16 vaccine. Editorial. NEJM 2003; 348:1404.
36. Bowen JT. Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. J Cutan Dis 1912; 30:241-255.
37. Feuger C, Nielsen VT. Intraepithelial neoplasia in the anal canal. The appearance and relation to genital neoplasia. ACTA Pathol Microbiol Immunol Scand 1986; 94:343-349.
38. Feuger C. Intraepithelial neoplasia in the anal canal and perianal area. Curr Topic Pathol 1990; 81:91-102.
39. Halverson AL. Perianal Bowen’s disease then and now: evolution of the treatment for anal high-grade intraepithelial neoplasia. Semin Colon Rectal Surg 2003; 14:213-217.
40. Brown SR, Skinner P, Tidy J, Smith JH, Sharp F, Hosie KB. Outcome after surgical resection for high-grade anal intraepithelial neoplasia (Bowen’s disease). Br J Surg 1999; 86:1063-1066.
41. Scholefield JH, Castle MT, Watson NFS. Malignant transformation of highgrade anal intraepithelial neoplasia. Br J Surg 2005; 92:1133-1136.
42. Abbasakoor F, Boulos PB. Anal intraepithelial neoplasia. Br J Surg 2005; 92:277-290.
43. Arbesman H, Ransohoff DF. Is Bowen’s disease a predictor for the development of internal malignancy? JAMA 1987; 257:516-518.
44. Chute CG, Chuang TY, Bergstralh EJ, Su WPD. The subsequent risk of internal cancer with Bowen’s disease. JAMA 1991; 266:816-819.
45. Marfing TF, Abel ME, Gallagher DM. Perianal Bowen’s disease and associated malignancies. Results of survey. Dis Colon Rectum 1987; 30:782-785.
46. Morgenthaler JA, Dietz DW, Matthew GM, Birmbaum EH, Kodner IJ, Fleshman JW. Outcomes, risk of other malignancies, and need for formal mapping procedures in patients with perianal Bowen’s disease. Dis Colon Rectum 2004; 47:1655-1661.
47. Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC. Perianal Bowen’s disease: a clinico-pathologic study of 47 patients. Dis Colon Rectum 1997; 40:1286-1293.
48. Samiento JM, Wolff BG, Burgart LJ, Frizelle FA, Ilstrup DM. Perianal Bowen’s disease. Associated tumors, human pappilloma virus, surgery, and other controversies. Dis Colon Rectum 1997; 40:912-918.
49. Gupta AK, Browne M, Bluhm R. Imiquimod: a review. J Cutan Med Surg 2002; 6:554-560.
50. Pehoushek J, Smith KJ. Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV positive man. Arch Dermatol 2001; 137:14-16.
51. Gottesman L. [Editorial]. Dis Colon Rectum 2004; 47:1660-1661.
52. Chang LK, Gottesman L, Breen EL, Bledag R. Anal dysplasia: controversies in management. Semin Colon Rectal Surg 2004; 15:233-238.
53. Nouri K, O’Connell C, Rivas MP. Imiquimod for the treatment of Bowen’s disease and invasive squamous cell carcinoma. Case J Drugs Dermatol 2003; 2:669-673.
54. Chen K, Shumack S. Treatment of Bowen’s disease using a cycle regimen of imiquimod 5% cream. Clin Exp Dermatol 2003; 28(suppl):10-12.
55. Graham BD, Jetmore AB, Foote JE, Arnold LK. Topical 5-fluorouracil in the management of extensive anal Bowen’s disease: a preferred approach. Dis Colon Rectum 2005; 48:444-450.
56. Skinner PP, Ogunbiyio A, Scholefield JH, et al. Skin appendage involvement in anal intraepithelial neoplasia. Br J Surg 1997; 84:675-678.
57. Berry JM, Jay N, Polefsky JM, Welton ML. State-of-the-art of high-resolution anoscopy as a tool to manage patients at risk for anal cancer. Semin Colon Rectal Surg 2004; 15:218-226.
58. Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM. The treatment options for perianal Bowen’s disease: survey of American Society of Colon and Rectal Surgeons members. Am Surg 2000; 66:686-688.
59. Hassan I, Horgan AF, Nivatvongs S. V-Y island flags for repair of large perianal defects. Am J Surg 2001; 181:363-365.
60. Scholefield JH. Anal intraepithelial neoplasia. Br J Surg 1999; 86:1364-1364.
61. Beahrs OH, Wilson SM. Carcinoma of the anus. Ann Surg 1976; 184:422-428.
62. Papillon J, Chassard JL. Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin. Dis Colon Rectum 1992; 35:422-429.
63. Moller C, Saksela E. Cancer of the anus and anal canal. Acta Chir Scand 1970; 136:340-348.
64. Nelson RL, Prasad L, Abcarian H. Anal carcinoma presenting as a perianal abscess or fistula. Arch Surg 1985; 120:632-635.
65. Fuchshuber PR, Rodriguez-Bigas M, Weber T, Peorelli NJ. Anal canal and perianal epidermoid cancers. Collective review. J Am Coll Surg 1997; 185:494-505.
66. Touboul E, Schlienger M, Buffat L, et al. Epidermoid carcinoma of the anal margin: 17 cases treated with curative-intent radiation therapy. Radiother Oncol 1995; 34:195-202.
67. Schraut WH, Wang C, Dawson PJ, Block GE. Depth of invasion, location, and size of cancer of the anus dictate operative treatment. Cancer 1983; 51: 1291-1296.
68. Cummings BJ, Keane TJ, Hawkins NV, O’Sullivan B. Treatment of perianal carcinoma by radiation (RT) or radiation plus chemotherapy (RTCT). Int J Radiat Oncol Biol Phys 1986; 12:170-173.
69. Paget J. On disease of the mammary areolar preceding cancer of the mammary gland. St. Bartholomew’s Hosp Report 1874; 10:87-89.
70. Tjandra J. Perianal Paget’s disease. Report of three cases. Dis Colon Rectum 1988; 31:462-466.
71. Darier J, Couillaud P. Sur un cas de maladie de Paget de la region kerineo-anal et scrotale. Ann de Dermatole et de Syph 1893; 4:25-31.
72. Armitage NC, Jass JR, Richman PI, Thomson JPS, Phillips RKS. Paget’s disease of the anus: a clinicopathological study. Br J Surg 1989; 76:60-63.
73. Morson BC, Dawson IMP, Day DW, Jass JR, Price AB, Williams GT. Morson and Dawson’s Gastrointestinal Pathology. London: Blackwell Scientific, 1990:673-675.
74. Rosai J. Ackerman’s Surgical Pathology. 8th ed. Louis: CV Mosby, 1996: 808-809.
75. Miller LR, McCunniff A, Randall ME. An immunohistochemical study of perianal Paget’s disease. Cancer 1992; 69:2166-2171.
76. Beck DE. Paget’s disease and Bowen’s disease of the anus. Semin Colon Rectal Surg 1995; 6:143-149.
77. Jensen SL, Sjolin KE, Shokouh Amiri MH, Hagen K, Harling H. Paget’s disease of the anal margin. Br J Surg 1988; 75:1089-1092.
78. Park JS, Kerner BA. Perianal Paget’s disease. Semin Colon Rectal Surg 2003; 14:218-221.
79. Ohnishi T, Watanabe S. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget’s disease. Br J Dermatol 2000; 142:243-247.
80. Goldblum JR, Hart WR. Perianal Paget’s disease. A histologic and immunohistochemical study with and without associated rectal adenocarcinoma. Am J Surg Pathol 1998; 22:170-179.
81. Brown RSD, Lankester KJ, McCormack M, Power DA, Spittle MF. Radiotherapy for perianal Paget’s disease. Clin Oncol 2002; 14:272-284.
82. Samiento JM, Wolff BG, Burgart LJ, Frizelle FA, Ilstrup DM. Paget’s disease of the perianal region—An aggressive disease? Dis Colon Rectum 1997; 40: 1187-1194.
83. McCarter MD, Quan SHQ, Busam K, Paty PH, Wong D, Guillem JG. Longterm outcome of perianal Paget’s disease. Dis Colon Rectum 2003; 46:612-616.
84. Marchesa P, Fazio VM, Oliart S, Goldblum JR, Lavery IC, Milsom JW. Longterm outcome of patients with perianal Paget’s disease. Am Surg Oncol 1997; 4:475-480.
85. Paterson CA, Young-Fadok TM, Dozois RR. Basal cell carcinoma of the perianal region. 20-year experience. Dis Colon Rectum 1999; 42:1200-1202.
86. Nielsen OV, Jensen SL. Basal cell carcinoma of the anus—a clinical study of 34 cases. BR J Surg 1981; 68:856-857.
87. Marks R, Gebauer K, Shumack S, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week doseresponse trial. J Am Acad Dermatol 2001; 44:807-813.
88. Gordon PH. Current status—perianal and anal canal neoplasms. Dis Colon Rectum 1990; 33:799-808.
89. Cintron J. Buschke-Loewenstein tumor of the perianal and anorectal region. Semin Colon Rectal Surg 1995; 6:135-139.
90. Heinzerling LM, Kempf W, Kamarashev J, Hafner J, Nestle FO. Treatment of verrucous carcinoma with Imiquimod and CO2 laser ablation. Dermatology 2003; 207:119-122.
91. Foust R, Dean PJ, Stoler MH, Monuddin SM. Intraepithelial neoplasia of the anal canal in hemorrhoidal tissue: a study of 19 cases. Hum Pathol 1991; 22:528-534.
92. Chang GJ, Berry JM, Jay N, Polefsky JM, Welton ML. Surgical treatment of high-grade anal squamous intraepithelial lesions. Dis Colon Rectum 2002; 45:453-458.
93. Jass JR, Sobin LH. Histological Typing of Intestinal Tumors. 2nd Heidelberg: Springer-Verlag, 1989:90.
94. Stearns MW Jr, Quan SHQ. Epidermoid carcinoma of the anorectum. Surg Gynecol Obstet 1970; 131:953-957.
95. Welch JP, Malt RA. Appraisal of the treatment of carcinoma of the anus and anal canal. Surg Gynecol Obstet 1977; 145:837-844.
96. Boman BM, Moertel CG, O’Connell MJ, et al. Carcinoma of the anal canal: a clinical and pathologic study of 188 cases. Cancer 1984; 54:114-125.
97. Cummings BJ. Treatment of primary epidermoid carcinoma of the anal canal. Int J Colorectal Dis 1987; 2:107-112.
98. Wade DS, Herrera I, Castillo NB, Petrelli NJ. Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique. Surg Gynecol Obstet 1989; 169:238-242.
99. Jensen SL, Hagen K, Harling H, Shokouh-Amiri MH, Nielsen OV. Long-term prognosis after radical treatment for squamous cell carcinoma of the anal canal and anal margin. Dis Colon Rectum 1988; 31:273-278.
100. Nigro ND, Vaitkevicuis VK, Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 17:354-356.
101. Nigro ND. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum 1984; 27:763-766
102. Sato H, Koh PK, Bartolo DCC. Management of anal canal cancer. Dis Colon Rectum 2005; 48:1301-1315.
103. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996; 14:2527-2539.
104. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-flourouracil, and mitomycin. UKCCCR anal cancer trial working party. UK Co-ordinating Committee on Cancer Research. Lancet 1996; 348: 1049-1054.
105. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol 1997; 15:2040-2049.
106. Eng C, Abbruzzese J, Minsky BD. Chemotherapy and radiation of anal canal cancer: the first approach. Surg Onc Clin N Am 2004; 13:309-320.
107. Stafford S, Martenson JA. Combined radiation and chemotherapy for carcinoma of the anal canal. Oncology 1998; 12:373-389.
108. Myerson RJ, Kong F, Birnbaum EH, et al. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 2001; 61:15-22.
109. Myerson RJ et al. Carcinoma of the anal canal. Am J Clin Oncol 1995; 18:32-39.
110. Roed H, Engelholm SA, Svendsen LB, et al. Pulsed dose rate (PDR) brachy therapy of anal carcinoma. Radiother Oncol 1996; 41:131-134.
111. Kapp KS, Geyer E, Gebhart FH, et al. Experience with split-course external beam irradiation Ir-chemotherapy and integrated in-192 high dose-rate brachytherapy in the treatment of primary carcinoma of the anal canal. Int J Radiat Oncol Bio Phys 2001; 49:997-1005.
112. Place RJ, Gregory SG, Huber PJ, Simmang CL. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum 2001; 44:506-512.
113. Kim JH, Sarani B, Orkin BA, et al. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum 2001; 44:1496-1502.
114. Berry JM, Polefsky JM, Welton ML. Anal cancer and its precursors in HIVpositive patients: perspectives and management. Surg Onc Clin N Am 2004; 13:355-373.
115. Blazy A. Hennequine, Gornet JM, et al. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum 2005; 48:1176-1181.
116. Cummings BJ, Keane TJ, O’Sullivan B, Wong ES, Cotton CN. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991; 21:1115-1125.
117. Tanum G, Tveit KM, Karlsen KO. Chemo-radiotherapy of anal carcinoma: tumor response and acute toxicity. Oncology 1993; 50:14-17.
118. Ellenhorn JD, Enker WE, Quan SHQ. Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus. Ann Surg Oncol 1994; 1:105-110.
119. Nguyen WD, Mitchell KM, Beck DE. Risk factors associated with requiring a stoma for the management of anal cancer. Dis Colon Rectum 2004; 47:843-846.
120. Longo WE, Vernava AM, Wade TP, Coplin MA, Virgo KS, Johnson FE. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy. Ann Surg 1994; 220:40-49.
121. Ghouti L, Houvenaeghel G, Moutardier V, et al. Salvage abdominoperineal resection after failure of conservative treatment in anal epidermoid cancer. Dis Colon Rectum 2005; 48:16-22.
122. Zelnick RS, Hass PA, Ajlouni M, Szilagyi E, Fox TA Jr. Results of abdominoperineal resections for failures after combination chemotherapy and radiation therapy for anal cancers. Dis Colon Rectum 1992; 35:574-578.
123. Gerard JP, Chapet O, Samiei F, et al. Management of inguinal lymph node metastasis in patients with carcinoma of the anal canal. Experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 2001; 92: 77-84.
124. Cummings BJ, Thomas GM, Keane TJ. Primary radiation therapy in the treatment of anal canal carcinoma. Dis Colon Rectum 1982; 25:778-782.
125. Papillon J, Montbarbon JF. Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis Colon Rectum 1987; 30:324-333.
126. Stearns MW, Urmacher C, Sternborg SE, Woodruff J, Attiyeh FF. Cancer of the anal canal. Curr Probl Cancer 1980; 4:1-44.
127. Ulmer C, Bembenek A, Gretschel S, et al. Refined staging by sentinel lymph node biopsy to individualize therapy in anal cancer. Ann Surg Onc 2004; 11(3 suppl):259s-262s.
128. Gupta N, Longo WE, Vernara AM, Wade TP, Johnson FE. Treatment of recurrent epidermoid carcinoma of the anal canal. Semin Colon Rectal Surg 1995; 6:160-165.
129. Gordon PH. Squamous cell carcinoma of the anal canal. Surg Clin North Am 1988; 68:1391-1399.
130. Tanum G, Tveit K, Karlsen KO, Hauer-Jensen M. Chemotherapy and radiation therapy for anal carcinoma. Cancer 1991; 67:2462-2466.
131. Basik M, Rodriguez-Bigas MA, Penetrante R, Pitrelli NJ. Prognosis and recurrence patterns of anal adenocarcinoma. Am J Surg 1995; 169:233-237.
132. Tarazi R, Nelson R. Adenocarcinoma of the anus. Semin Colon Rectal Surg 1995; 6:169-173.
133. Beal KP, Wong D, Guillem JG, et al. Primary adenocarcinoma of the anus treated with combined modality therapy. Dis Colon Rectum 2003; 46: 1320-1324.
134. Hobbs CM, Lowry MA, Owen D, Sobin LH. Anal gland carcinoma. Cancer 2001; 92:2045-2049.
135. Morson BC, Sobin LH. Histologic Typing of Intestinal Tumors. Geneva: World Health Organization, 1976.
136. Jensen SL, Shokouh-Amiri MH, Hagen K, Harling H, Nielsen OV. Adenocarcinoma of the anal ducts: a series of 21 cases. Dis Colon Rectum 1988; 31: 268-272.
137. Perkowski PE, Surrells DL, Evans JT, Nopajaronsri C, Johnson LW. Anal duct carcinoma: case report and review of the literature. Am Surg 2000; 66: 1149-1152.
138. Fenger C. Anal canal tumors and their precursors. Pathol Annu 1988; 23:45-66.
139. Schaffzin DM, Stahl TJ, Smith LE. Perianal mucinous adenocarcinoma: unusual case presentations and review of the literature. Arch Path Lab Med 2001; 125:1074-1077.
140. Jensen SL, Nielsen OV. Anal duct carcinoma [editorial]. Dis Colon Rectum 1989; 32:355-357.
141. Getz SB Jr, Ough YD, Patterson RB, Kovalcik PJ. Mucinous adenocarcinoma developing in chronic anal fistula: report of two cases and review of the literature. Dis Colon Rectum 1981; 24:562-566.
142. Belkacemi Y, Berger C, Poortmans P, et al. Management of primary anal canal adenocarcinoma: a large retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys 2003; 56:1274-1283.
143. Abel ME, Chiu YSY, Russell TR, Volpe PA. Adenocarcinoma of the anal glands. Results of a survey. Dis Colon Rectum 1993; 36:383-387.
144. Tarazi R, Nelson RL. Anal adenocarcinoma: a comprehensive review. Semin Colon Rectal Surg 1994; 10:235-240.
145. Papagikos M, Crane CH, Skibber J, et al. Chemoradiation for adenocarcinoma of the anus. Int J Radiat Oncol Biol Phys 2003; 55:669-678.
146. Paterson C, Musselman L, Chorneyko K, Reid S, Rawlinson J. Merkel cell (neuroendocrine) carcinoma of the anal canal. Dis Colon Rectum 2003; 46:676-678.
147. Coquard R. Merkel cell carcinoma of the anal canal: importance of radiotherapy [Editorial]. Dis Colon Rectum 2004; 47:256-257.
148. Mason JK, Helwig EB. Anorectal melanoma. Cancer 1966; 19:39-50.
149. Thibault C, Sagar P, Nivatvongs S, Wolff BG. Anorectal melanoma: an incurable disease? Dis Colon Rectum 1997; 40:661--668.
150. Cagir B, Whiteford MH, Topham A, Rakinic J, Fry RD. Changing epidemiology of anorectal melanoma. Dis Colon Rectum 1999; 42:1203-1208.
151. Ward MWN, Romano G, Nicholls RJ. The surgical treatment of anorectal malignant melanoma. Br J Surg 1986; 73:68-69.
152. Werdin C, Limas C, Knodell RG. Primary malignant melanoma of the rectum. Evidence for origination from rectal mucosal melanocytes. Cancer 1988; 61:1364-1370.
153. Quan SHQ. Malignant melanoma of the anorectum. Semin Colon Rectal Surg 1995; 6:166-168.
154. Antoniuk PM, Tjandra JJ, Webb BW, Petras RE, Milsom JW, Pazio VW. Anorectal malignant melanoma has a poor prognosis. Int J Colorectal Dis 1993; 8:81-86.
155. Chiu YS, Unni KK, Beart RW Jr. Malignant melanoma of the anorectum. Dis Colon Rectum 1980; 23:122-124.
156. Bullard KM, Tuttle TM, Rothenberger DA, et al. Surgical therapy for anorectal melanoma. J Am Coll Surg 2003; 196:206-211.
157. Malik A, Hull TL, Milsom J. Long-term survivor of anorectal melanoma. Report of a case. Dis Colon Rectum 2002; 45:1412-1417.
158. Cooper PH, Mills SE, Allen MS Jr. Malignant melanoma of the anus. Report of 12 patients and analysis of 255 additional cases. Dis Colon Rectum 1982; 25:693-703.
159. Wolff BG. Anorectal melanoma [Editorial]. Dis Colon Rectum 2002; 45:1415.
160. Brady MS, Kavolius JP, Quan SHQ. Anorectal melanoma. A 64 year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum 1995; 38: 146-151.
161. Pessaux P, Pocard M, Elias D, et al. Surgical management of primary anorectal melanoma. Br J Surg 2004; 91:1183-1187.
162. Ward MW, Romano G, Nichollo RJ. The surgical treatment of anorectal malignant melanoma. Br J Surg 1996; 73:68-69.
163. Roumen RMH. Anorectal melanoma in the Netherlands: a report of 63 patients. Eur J Surg Onc 1996; 22:598-601.
164. Ross M, Pezzi C, Pezzi T, Meurer D, Hickey R, Balch C. Patterns of failure in anorectal melanoma. A guide to surgical therapy. Arch Surg 1990; 125: 313-316.
165. Slingluff CL Jr, Vollmer RT, Seigler HF. Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery 1990; 107:1-9.
166. Goldman S, Glimelius B, Pahlman L. Anorectal malignant melanoma in Sweden. Report of 49 patients. Dis Colon Rectum 1990; 33:874-877.